vimarsana.com

Latest Breaking News On - டைவா மூலதனம் ஹோல்டிங்ஸ் - Page 1 : vimarsana.com

Ultrasound Disruptor Exo Secures $220M in Series C Funding Round – Consumer Electronics Net

Ultrasound Disruptor Exo Secures $220M in Series C Funding Round – Consumer Electronics Net
consumerelectronicsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from consumerelectronicsnet.com Daily Mail and Mail on Sunday newspapers.

SiLC Technologies Raises $17M Series A Funding Round to Advance Machine Vision Applications

Over the last year, SiLC has provided development systems to customers that are at the forefront of their respective market segments, including mobility, industrial machine vision, robotics, augmented reality, and consumer applications. The new funds will help further customer traction and support bringing these products to market. Currently being readied for broad deployment, SiLC s advanced, production-ready 4D+ Vision Chip offers best-in-class performance metrics across range, resolution and accuracy for LiDARs. The 4D+ Vision Chip accomplishes this in a much smaller footprint and on an already proven scalable manufacturing platform. Additionally, it is the only solution on the market adding critical vector measurements including velocity, light polarization, and reflectivity. The additional information derived from this data provides context and greatly improves perception of the environment, a breakthrough that has wide-ranging applications for autonomous vehicles, biometrics

Huma raises $130 million financing to scale its digital health platform for better care and research

LONDON and NEW YORK  , May 12, 2021 /PRNewswire/  Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately $130 million. The investment will scale Huma s modular platform which can power digital hospitals at home nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials. Huma s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research. Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV , Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.